Moreover, CD57 upregulation on the activated T cells was unrelated to the stemness of the tumor cells, since differentiated patient-derived GBM cells, which kept CD57 expression, still induced CD57 expression on the activated T cells. The gene discussed is B3GAT1; the disease is glioblastoma.